Compare CNS & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNS | ASH |
|---|---|---|
| Founded | 1986 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Specialty Chemicals |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.9B |
| IPO Year | 2004 | N/A |
| Metric | CNS | ASH |
|---|---|---|
| Price | $62.82 | $64.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $72.50 | $65.86 |
| AVG Volume (30 Days) | 373.5K | ★ 655.9K |
| Earning Date | 01-22-2026 | 02-02-2026 |
| Dividend Yield | ★ 4.04% | 2.72% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.97 | N/A |
| Revenue | $556,116,000.00 | ★ $1,805,000,000.00 |
| Revenue This Year | $8.88 | $3.34 |
| Revenue Next Year | $7.22 | $3.55 |
| P/E Ratio | $20.67 | ★ N/A |
| Revenue Growth | ★ 7.48 | N/A |
| 52 Week Low | $58.39 | $45.21 |
| 52 Week High | $89.67 | $67.39 |
| Indicator | CNS | ASH |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 62.85 |
| Support Level | $63.35 | $57.87 |
| Resistance Level | $67.26 | $64.09 |
| Average True Range (ATR) | 2.10 | 1.95 |
| MACD | -0.72 | -0.23 |
| Stochastic Oscillator | 25.86 | 84.44 |
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two thirds of its $90.9 billion in managed assets at the end of September 2025. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (26%) of its managed assets (base management fees) from institutional clients, 48% (54%) from open-end funds, and 13% (20%) from closed-end funds.
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.